Xcell Therapeutics Inc. (KOSDAQ:373110)
1,415.00
+64.00 (4.74%)
Mar 10, 2026, 3:30 PM KST
-65.90% (1Y)
| Market Cap | 23.36B |
| Revenue (ttm) | 1.36B |
| Net Income (ttm) | -10.01B |
| Shares Out | 17.29M |
| EPS (ttm) | -915.30 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 47,705 |
| Average Volume | 762,264 |
| Open | 1,399.00 |
| Previous Close | 1,351.00 |
| Day's Range | 1,372.00 - 1,420.00 |
| 52-Week Range | 1,301.00 - 4,530.00 |
| Beta | n/a |
| RSI | 37.70 |
| Earnings Date | Mar 30, 2026 |